Scientific article

Diabète de l'enfant, de l'insulino-vers l'immunothérapie: une prise en charge globale du présent vers le futur

Published inRevue médicale suisse, vol. 7, no. 283, p. 430-436
Publication date2011

Diabetes type I (DTI) is an autoimmune disease characterized by a progressive destruction of the insulin producing beta cells of the pancreas that requires insulin substitution therapy. Recent epidemiological data show an annual increase of the incidence of DTI of 3.9%. Children with new onset diabetes typically present with polyuria, polydipsia and weight loss. As of today no cure for DTI exists. However new therapeutic immunomodulary approaches are under investigation. In the meantime adherence to insulin therapy is mandatory to achieve near physiological glucose levels. Monogenic forms of diabetes remain rare in children, but their diagnosis is important in order to propose a specific treatment. A critical period for the diabetic patient is the transition from pediatric to adult care.

  • Child
  • Diabetes Mellitus, Type 1/diagnosis/drug therapy/epidemiology/immunology
  • Drug Therapy, Combination
  • HLA Antigens/drug effects
  • Humans
  • Hypoglycemic Agents/therapeutic use
  • Immunosuppressive Agents/therapeutic use
  • Incidence
  • Insulin/therapeutic use
  • Polyuria/immunology
  • Switzerland/epidemiology
  • Weight Loss/immunology
Citation (ISO format)
DIRLEWANGER, Mijam et al. Diabète de l’enfant, de l’insulino-vers l’immunothérapie: une prise en charge globale du présent vers le futur. In: Revue médicale suisse, 2011, vol. 7, n° 283, p. 430–436.
Main files (1)
Article (Accepted version)
ISSN of the journal1660-9379

Technical informations

Creation12/13/2012 3:03:00 PM
First validation12/13/2012 3:03:00 PM
Update time03/14/2023 7:58:34 PM
Status update03/14/2023 7:58:33 PM
Last indexation01/16/2024 1:00:09 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack